Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/05/2003EP1357811A1 Composition and method for smoke detoxification
11/05/2003EP1189749B1 Composite laminate and method for its production
11/05/2003EP1176961B1 Nicotine delivery systems
11/05/2003EP1051194B9 Process for making absorbable microparticles
11/05/2003EP1037670B1 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
11/05/2003EP1023069B1 Nicotine compositions and methods of formulation thereof
11/05/2003EP1009436B1 Acridine derivative for increasing the oral bioavailability of taxol
11/05/2003EP1007034B1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
11/05/2003EP0973527B1 Extended release formulations of clarithromycin
11/05/2003EP0971703B9 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
11/05/2003EP0871432B1 Use of a composition containing polyether block copolymers
11/05/2003EP0863747B1 Stimulation of hair follicles
11/05/2003EP0839039B1 Paroxetine controlled release compositions
11/05/2003EP0814835B1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition
11/05/2003EP0813413B1 Corticosteroid-containing foam
11/05/2003EP0777679B1 Delivery of nucleic acids
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454205A Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
11/05/2003CN1454099A Dendrimer-photosensitizer complexes for medical applications
11/05/2003CN1454098A Depletion method of blood plasma ascorbate
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454092A Use of bioactive fraction from cow urine distillate (ÔÇÿGo-mutraÔÇÖ) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
11/05/2003CN1454085A Clear aqueous anaesthetic composition
11/05/2003CN1454084A Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
11/05/2003CN1454082A Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
11/05/2003CN1453043A Microbiological cellulose injury dressing for treating chronic injury
11/05/2003CN1453038A Application of agrose in preparing medicine for prostate hyperplosia
11/05/2003CN1452982A Mucosa administrated Ribavirin prepn for preventing & curing SARS and its prepn process
11/05/2003CN1452976A Compound glucose injection with clindamycin and metronidazole
11/05/2003CN1126930C Desiccant, dehydration therewith and dehydrated product obtainable thereby
11/05/2003CN1126568C Adjuvant used in vaccine
11/05/2003CN1126567C Stalilized composition for NGF and reagent box and preparing process thereof
11/05/2003CN1126564C Application of phospholipid complexes of extracts of civitis vinifera as anti-atherosclerotic agent
11/05/2003CN1126548C Use of zine hyaluronate against peptic ulcer
11/05/2003CN1126547C Lentinan holosida freeze-dried powder injecta and its preparation
11/05/2003CN1126543C Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates
11/05/2003CN1126537C Locally administrable, biodegradable and sustained-release pharmaceutical composition for treating periodontitis and preparation thereof
11/05/2003CN1126535C Aqueous suspension for nasal administration of loteprednol
11/05/2003CN1126533C Improvement of organic composition or improvement related to organic composition
11/04/2003US6643488 Intermediate transfer drum for electro-photographic process and image forming apparatus using the same
11/04/2003US6642411 Compounds and compositions for delivering active agents
11/04/2003US6642363 Bonded to a peptide which promotes cell adhesion and growth; use in drug delivery, cell transplantation and tissue engineering
11/04/2003US6642276 Controlled release macrolide pharmaceutical formulations
11/04/2003US6642214 Oligomer consisting of two cyclodextrin molecules joined by bifunctional spacer, optionally having affinity group which interacts with molecular target structure; physical inclusion complex formed with drug reduces side effects
11/04/2003US6642205 Methods and compositions for reducing side effects in chemotherapeutic treatments
11/04/2003US6641999 Probing method for identifying antibodies specific for selected antigens
11/04/2003US6641843 Pharmaceutical compositions
11/04/2003US6641841 N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and low sustituted hydroxypropylcellulose; controlling the blood sugar levels of diabetics.
11/04/2003US6641840 Sustained release formulations for growth hormone secretagogues
11/04/2003US6641838 Effervescent drug delivery system for oral administration
11/04/2003US6641837 Flavored vegetable starch capsule
11/04/2003US6641834 Quinoxaline component is selected from qinoxaline, a (2-imiozoline -2-ylamino) quinoxaline, a 5-bromo-6-(2-imidozolin-2- ylamino) quinoxaline, a tartrate of 5-bromo-6-(2-imidozolin-2-ylamino) quinoxaline or derivatives
11/04/2003US6641833 Extended release of paclitaxel by intraperitoneal administration
11/04/2003US6641820 Treating a bone tumor, in particular pain associated with bone tumor, by administration to a patient of a therapeutically effective amount of an agent are disclosed. The agent may include a clostridial neurotoxin component attached to target
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003US6641800 Administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer soluble in the liquefied hydrofluoroalkane which is selected from polymers
11/04/2003US6641798 Tumor-targeted optical contrast agents
11/04/2003CA2175470C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
11/04/2003CA2073616C Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose
10/2003
10/30/2003WO2003089593A2 Adjuvant enhanced immunotherapy
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089574A2 Synthetic glyco-lipo-peptides as vaccines
10/30/2003WO2003089568A2 Method of inhibiting restenosis
10/30/2003WO2003089458A2 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003WO2003089440A1 Polymorph of ascomycin derivative
10/30/2003WO2003089010A1 Glycodendrimers having biological activity
10/30/2003WO2003089009A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/30/2003WO2003089008A1 Novel biomaterials, their preparation and use
10/30/2003WO2003089000A2 Anti-hiv composition, production method thereof and medicament
10/30/2003WO2003088974A1 Pharmaceutical composition
10/30/2003WO2003088973A1 Combination of brimonidine and timolol for topical ophthalmic use
10/30/2003WO2003088957A1 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
10/30/2003WO2003088956A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003WO2003088955A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amine and lactic acid or a lactic acid salt
10/30/2003WO2003088952A1 Sustained release of guaifenesin combination drugs
10/30/2003WO2003088950A1 System for enhanced targeted delivery
10/30/2003WO2003088946A1 Polymer compositions that stabilize and control the release of formaldehyde-treated vaccine antigens
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088944A1 Dry powder inhalant composition
10/30/2003WO2003088943A1 Dry powder compositions
10/30/2003WO2003088923A2 Methods of treating ileus
10/30/2003WO2003088920A2 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics
10/30/2003WO2003088913A2 Peptide deformylase activated prodrugs
10/30/2003WO2003088808A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003088765A2 Functional foods containing a phospholipid-containing stable matrix
10/30/2003WO2003088761A2 Physiologically compatible, phospholipid-containing, stable and hard matrix
10/30/2003WO2003088755A1 Delivery systems for functional ingredients
10/30/2003WO2003088749A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003WO2003057837A8 Methods for using anti-muc18 antibodies
10/30/2003WO2003055527A3 Immunoconjugates useful for treatment of tumours
10/30/2003WO2003053365A3 Syn3 compositions and methods
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
10/30/2003WO2003051294A3 Mitocidal compositions and methods
10/30/2003WO2003049783A3 Device and methods for harvesting tissue samples of known geometry
10/30/2003WO2003049680A3 Compositions containing both sedative and non-sedative antihistamines
10/30/2003WO2003047633A3 Treatment of angiogenesis disorders using targeted nanoparticles
10/30/2003WO2003045319A3 Targeted therapeutics and uses thereof
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003032899A3 Methods and materials for targeting and affecting selected cells
1 ... 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 ... 1712